Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer PatientsK. L. Juliëtte Schmidt, Wim J. E. Tissing, Stefan Nierkens et al.|Cancers|2023Cited by 17
Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancerK. L. Juliëtte Schmidt, Wim J. E. Tissing, Noortje R. Severeijns et al.|EJC Paediatric Oncology|2024Cited by 3